Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.
about
SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobankingT Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeHematopoietic cell transplantation for Crohn's disease; is it time?High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseasesCell therapy for autoimmune diseasesNotes on the kidney and its diseases for the neurologist.Blood stem cells as therapy for severe lupus.Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case studyFatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus.Stem cell transplantation for rheumatic autoimmune diseases.Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantationManipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.Immune re-education following autologous hematopoietic stem cell transplantation.Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases.Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications.Stem cell transplantation: progress in Asia.Autologous haemopoietic stem cell transplantation for autoimmune diseases.An update on stem cell transplantation in autoimmune rheumatologic disorders.Update on stem cell transplantation for systemic sclerosis: recent trial results.Stem cell therapies for systemic lupus erythematosus: current progress and established evidence.Autologous hematopoietic stem cells for refractory Crohn's disease.Cell Therapy for Multiple Sclerosis.Novel alginate three-dimensional static and rotating culture systems for effective ex vivo amplification of human cord blood hematopoietic stem cells and in vivo functional analysis of amplified cells in NOD/SCID mice.Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease.Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting.Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens.Changes in the number of CD8⁺ T lymphocytes in the peripheral blood of patients with various autoimmune diseases after autologous hematopoietic stem cell transplantations and their relations to the survival times.Targeted gene therapy of autoimmune diseases: advances and prospects.Ex vivo amplification of human hematopoietic stem and progenitor cells in an alginate three-dimensional culture system.The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy.The origin of increasing utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SAD). Introduction.
P2860
Q26853573-8A08F070-E770-4226-9C3E-CD044AFE5BEAQ28072227-25D30C8C-625E-4C04-9F0C-67850BF78EA8Q34017756-5BC29DD6-EE6A-4C5B-9743-9B75324C120CQ34986999-0C5592F1-E0D2-439B-B88B-3855E79F73EDQ35868954-45F1189B-B197-4AF0-B4CB-17504EAAD7C0Q36227382-86E86161-71D7-462C-B9AD-475FF6963E29Q36239643-FECA2580-9214-49B6-B420-A32021CAB538Q36401901-F614A577-F8B5-4385-83F8-A92AF4A45F77Q36417451-591B30FD-2937-476D-B949-2B86500C890BQ36993217-2560FA08-9C6B-4CEB-A74F-90E43E00F52CQ36997172-DD887B88-2126-4E96-AC2F-A2FD76C45575Q37211290-B7B42654-F8D7-444C-9BF9-E31CEAA6AB01Q37311055-B84DF8D9-7166-4A80-ADB5-CF093398569EQ37311065-175EFDF0-EFE5-4525-A691-97C7C76F50C1Q37311073-20C3E207-9E3D-484C-9F0E-A78CBECC4D79Q37687432-1408E734-B32B-4E19-8922-041F44B70F17Q37800307-3BA7CB78-AB5E-49A0-91AC-D3310B637CC3Q37879139-7E4A67B3-A363-4164-BC09-0ACAE77BB6DEQ38041499-7052A3A1-5BA7-4968-8B7D-AE67D54971D4Q38091659-56E31ADD-5D64-43AB-94DA-76A4D32192F1Q38431886-646D083B-DC6B-4143-982B-7C9C17E1122FQ39192366-EA54BDF7-75DB-4E31-9378-1F22979DB2C0Q39233323-38676BC2-A262-4E44-A551-D9A912C359DFQ39472282-FF2B6A17-BD3D-4067-BC6E-53803DB16E39Q39649689-36B95E83-4A15-464F-837D-8CB7D1B66AB0Q42659414-0CAF621F-7B1B-4C28-BC2B-1CAF6939F71CQ45263742-192012C8-8BF7-4018-83CE-3FF67D04CD51Q45732703-0C803CF8-306D-4BCF-A17B-6DD78F60E576Q45859107-F7E1CDBC-FF40-42DF-BB76-5D3AABAB4C58Q51601888-C627B140-F7D4-44AB-8F85-D70A21B9E556Q51714820-C55F5DC2-E04E-4C04-8CDF-E6A630107CDEQ53443452-C84B010A-29FA-417B-9329-741624B72DB2
P2860
Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Haematopoietic stem cell trans ...... trials and future directions.
@ast
Haematopoietic stem cell trans ...... trials and future directions.
@en
type
label
Haematopoietic stem cell trans ...... trials and future directions.
@ast
Haematopoietic stem cell trans ...... trials and future directions.
@en
prefLabel
Haematopoietic stem cell trans ...... trials and future directions.
@ast
Haematopoietic stem cell trans ...... trials and future directions.
@en
P2860
P1476
Haematopoietic stem cell trans ...... trials and future directions.
@en
P2093
P2860
P356
10.1111/J.1365-2249.2005.02806.X
P577
2005-07-01T00:00:00Z